
    
      The aim of this prospective, randomized study is to investigate the effect of Bulkamid
      injection for women with urinary stress incontinence and not suitable to TVT-procedure
      because of suspected ISD and compare this treatment with no or traditional treatment. The
      primary endpoint for efficacy will be reduction of leakage during pad-test at 2 months
      compared with pad- test before injection.

      Secondary endpoints will be patient satisfaction measured at both 2 and 12 months using a
      questionnaire and the number of side effects.
    
  